Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Buy now fake rolex


US, NZ back patent waivers

Posted 6 May 2021 PM

The US will back the World Health Organisation's push to have intellectual property rules around COVID-19 vaccines relaxed, ignoring pharma industry fears it will undermine the global pandemic response and compromise safety. 

Share prices of the key COVID-19 vaccine manufacturers fell following the announcement.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here

Top of the Hill
Could access probe be for nothing?
Significant industry participation but what outcome?
Approvals Action
Injectable antibiotic ticked
Fresenius Kabi adds to Gram-positive options